Abstract
Fonsecaea monophora is one of the common pathogenic species of Chromoblastomycosis (CBM). Antimicrobial photodynamic therapy (aPDT) shows promise as a new treatment for CBM. In this study, we evaluated the effectiveness of COP1T-HA which is a porous organic cage and aPDT against Fonsecaea spp. in vitro.
| Original language | English |
|---|---|
| Pages (from-to) | 413-417 |
| Number of pages | 5 |
| Journal | Mycology |
| Volume | 16 |
| Issue number | 1 |
| DOIs | |
| State | Published - 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- COP1T-HA
- Chromoblastomycosis (CBM)
- Fonsecaea monophora
- antimicrobial photodynamic therapy (aPDT)
Fingerprint
Dive into the research topics of 'Improving treatment of chromoblastomycosis: the potential of COP1T-HA and antimicrobial photodynamic therapy against Fonsecaea monophora in vitro'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver